Peptide therapy TikTok claims: what the science actually supports

What did @paulbakhtiar actually say?

The creator named three peptides as the best options for anxiety: selank, semax, and oxytocin. The reasoning offered was that they "reduce anxiety by really bouncing out neurotransmitters and lowering inflammation in the brain." He also said they "promote calm focus without sedation" and help people feel "calmer and happier by helping their brain relax."

To be fair, he named three peptides that researchers have actually studied in the context of anxiety. That's a better starting point than most peptide content on TikTok, which tends to repeat gym-bro mythology. But the explanation of how they work is vague to the point of being misleading, and the clinical picture is far more complicated than this video lets on.

Does the science back this up?

Partly. Selank has the strongest anxiety-related research, though almost all of it comes from Russian clinical trials. Semax has nootropic and neuroprotective data but thinner anxiety-specific evidence. Oxytocin's relationship with anxiety is genuinely complicated.

Selank is a synthetic analog of tuftsin, and Russian studies including Semenova et al. (2010, Bulletin of Experimental Biology and Medicine) found anxiolytic effects comparable to benzodiazepines in some patients, without sedation or dependence. That part of the video's claim holds up. Semax (an ACTH analog) has been studied for cognitive function and mood, with Dolotov et al. (2006, Journal of Molecular Neuroscience) showing BDNF upregulation, which could indirectly support mood regulation. As for oxytocin, the story is not as clean. Shamay-Tsoory and Abu-Akel (2016, Trends in Cognitive Sciences) documented that oxytocin can actually increase anxiety in certain social contexts and threat environments. Calling it simply an anti-anxiety peptide is an oversimplification the evidence does not support.

What did they get wrong (or right)?

The phrase "bouncing out neurotransmitters" is not a real pharmacological concept, and it deserves to be called out plainly. Selank appears to modulate GABA-A receptors and influence serotonin metabolism. Semax affects dopaminergic and serotonergic pathways. These are specific mechanisms, and dumbing them down to "balancing" does viewers a disservice.

The claim that these peptides lower "inflammation in the brain" is partially supportable for semax, which has shown anti-inflammatory effects in rodent models of brain injury (Gusev et al., 2002, Cerebrovascular Diseases). For selank, there is some cytokine-modulating data. For oxytocin, the anti-inflammatory neurological evidence is thin in humans.

Where the creator deserves credit: selank and semax genuinely do appear to produce anxiolytic or calming effects without the sedation associated with benzodiazepines, based on available data. That distinction is real and worth knowing. But none of these peptides are FDA-approved for anxiety disorders, none have large-scale Phase III human trials in Western regulatory systems, and presenting them as simply "the best peptides for anxiety" skips over all of that.

What should you actually know?

These peptides are not approved treatments for anxiety disorders. If you are managing clinical anxiety, a licensed provider should be your first call, not a TikTok recommendation stack.

Selank and semax are primarily researched in Russia, and most published trials are small, lack independent replication, and were conducted by researchers with institutional ties to the compounds. That does not make the findings false, but it means the evidence base is weaker than the confident tone of videos like this implies. Oxytocin is available as a nasal spray in research settings but its effects on anxiety are context-dependent and not reliably positive across populations.

There are also real practical concerns. These are compounded or research-grade peptides in most Western markets. Quality control varies significantly between suppliers. Dosing, administration method, and individual neurochemistry all affect outcomes in ways a short video cannot address.

• Selank: most promising anxiety data, but almost exclusively from Russian trials
• Semax: stronger nootropic than anxiolytic evidence in current literature
• Oxytocin: bidirectional anxiety effects depending on context, not a simple calming agent
• None are FDA-approved for psychiatric indications
• "Calm focus without sedation" is a reasonable characterization for selank specifically, less so for the others